Impact of the change from the seventh to eighth edition of the AJCC TNM classification of malignant tumours and comparison with the MACIS prognostic scoring system in non‐medullary thyroid cancer
BJS Open2019Vol. 3(5), pp. 623–628
Citations Over TimeTop 15% of 2019 papers
Abstract
Compared with TNM7, TNM8 downstaged more patients to stage I and accurately reflected worse prognosis for stage IV disease. TNM8 is an inferior predictor of mortality compared with MACIS.
Related Papers
- → Protein Kinase Inhibitor Therapy in Advanced Thyroid Cancer: Ethical Challenges and Potential Solutions(2014)8 cited
- → Medullary Thyroid Cancer(2000)3 cited
- → Medullary and non-medullary thyroid cancer in a family(2004)
- → Targeted and Salvage Therapies Benefit Patients With Thyroid Cancer(2015)
- → Medullary Cancer(2007)